5 ASX 200 shares set to rise by 30% to 45% over the next 12 months: Experts

If you're looking for opportunities during this traditionally weaker month for the market, here are some expert tips.

S&P/ASX 200 Index (ASX: XJO) shares shed 0.52% yesterday to close at 8,803.5 points.

The benchmark index has slipped 2% already this month.

If you're looking for opportunities during this traditionally weaker month for the market, here are some expert tips.

a group of young people dance together with their hands in the air, moving to music as they celebrate ASX 200 shares rising today.

Image source: Getty Images

5 ASX 200 shares with ambitious price targets

A price target is a broker's best guess as to where a stock may be trading by this time next year.

The following ASX 200 shares have price targets suggesting 30% to 45% upside from here.

Let's take a look.

AGL Energy Limited (ASX: AGL)

The AGL share price closed at $8.24 on Tuesday, up 0.12%.

Macquarie has an outperform rating on this ASX 200 utilities share.

Following the energy retailer's FY25 results, the broker put a $10.91 price target on AGL shares.

This indicates a potential rise of more than 30% over the next 12 months.

CSL Ltd (ASX: CSL)

The CSL share price closed at $209.94, down 1.61% yesterday. (One particular factor weighed it down.)

Macquarie has an outperform rating on the ASX 200 healthcare share following the FY25 report.

The broker's price target is $295.90, implying about 40% upside over the next 12 months.

CSL was among a bunch of companies that announced share buyback programs during earnings season.

After its share price slumped, CSL is now among 10 ASX 200 shares trading on a forward P/E ratio below the market average.

Polynovo Ltd (ASX: PNV)

The Polynovo share price closed at $1.39 on Tuesday, down 5.78%.

Macquarie has an outperform rating on Polynovo shares with a price target of $2.

While that's a reduction from the previous target of $2.45, it's still 44% higher than where this healthcare share is now.

After Polynovo's FY25 results, Macquarie noted "several near-term positive catalysts for PolyNovo, with a significant longer-term opportunity in additional indications."

Polynovo is among 9 ASX 200 shares that will be dropped from the benchmark index in the next rebalance, effective 22 September.

WiseTech Global Ltd (ASX: WTC)

The Wisetech share price closed at $94.36, down 1.04%.

Morgans retained its buy rating on the software provider after the FY25 report.

The ASX 200 tech share was among 11 ASX 100 companies that had the biggest price drops after their results.

Morgans trimmed its Wisetech price target to $127.60, suggesting 35% potential growth from here.

Wisetech is one of more than 35 ASX shares going ex-dividend this week.

Temple & Webster Group Ltd (ASX: TPW)

This ASX 200 retail share finished the day at $22.93 on Tuesday, up 1.87%.

Macquarie has an outperform rating on Temple & Webster shares after its FY25 report.

The broker has a price target of $31.30 on the online furniture retailer.

This implies more than 35% capital growth potential over the next 12 months.

Macquarie analyst James Wilson commented:

We maintain our Outperform rating — seeing momentum from accelerating sales and earnings growth (greater active customers, greater conversion, increased revenue per customer, further operating leverage, and an onmarket buyback).

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, PolyNovo, Temple & Webster Group, and WiseTech Global. The Motley Fool Australia has positions in and has recommended Macquarie Group and WiseTech Global. The Motley Fool Australia has recommended CSL, PolyNovo, and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Analysts warn that these popular ASX shares as sells

These shares have been given sell ratings by experts. But why?

Read more »

Man smiling ahead while working on his MacBook.
Broker Notes

Experts name 3 ASX 200 shares to buy

These shares have been given the thumbs up this week.

Read more »

Man analysing data on his laptop.
Broker Notes

Buy, hold, sell: Nick Scali, Medibank Private, BHP shares

Let's start the new week with some fresh ratings from the experts.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Broker Notes

6 ASX stocks receiving analyst downgrades this week

Brokers reduced their ratings on NextDC, Ampol, Regis Resources, and other stocks this week. 

Read more »

Facebook thumbs up symbol surrounded by boxes with the word 'Like'.
Broker Notes

6 ASX stocks upgraded by leading brokers this week

Brokers have raised their ratings on Pro Medicus, South32, New Hope, and others. 

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

6 ASX shares experts are backing amid the market downturn

Brokers maintained a positive view on Qantas, NAB, Maas Group, BHP, and other shares.

Read more »

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Should you buy Hub24, Northern Star, and Transurban shares?

Morgans has given its verdict on these shares. Is it time to buy? Let's find out.

Read more »